Skip to main content

Third Wave Japan Pockets $5.3M in Stock Placement

NEW YORK (GenomeWeb News) — Third Wave Japan, a subsidiary of Third Wave Technologies, has raised roughly $5.3 million in a stock placement, the company stated in a filing with the Securities and Exchange Commission yesterday.
 
Third Wave Japan sold 7,112 shares of common stock at ¥90,000 ($743) per share to Mitsubishi, Shimadzu, CSK Institute for Sustainability, Daiichi Pure Chemicals, BML, and Toppan Printing.
 
Third Wave Japan said the investors purchased roughly 12.9 percent of its outstanding shares and around 12.4 percent of the company’s outstanding equity.
 
Including previous investments, Mitsubishi and CSK now own around 27 percent of Third Wave Japan, or 31 percent after exercise of warrants.
 
The company said the convertible Series A preferred stock has an 8-percent, non-cumulative dividend.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.